Skip to content

Clinical trials

Phase 2 Glucose Metabolism Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Metabolism Disorders Phase: Phase 2 Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20062
20072
20085
20093
20102
20132
20142
20151
20162
20172
20185
20191
20203
20212
20221
20232
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated6
Recruiting5
Unknown status2
Withdrawn2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda7
Albert Einstein College of Medicine4
Eli Lilly and Company2
Johnny Ludvigsson2
VIVUS LLC2
Akcea Therapeutics1
Calibra Medical, Inc.1
Diamyd Medical AB1
Genfit1
Hospital de Clinicas de Porto Alegre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Metabolism Disorders42
Diabetes Mellitus29
Diabetes Mellitus, Type 220
Metabolic Diseases20
Endocrine System Diseases14
Insulin Resistance8
Diabetes Mellitus, Type 17
Dyslipidemias7
Diabetes Mellitus, Lipoatrophic6
Autoimmune Diseases5

Trials

Showing 76 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.